UK Markets close in 7 hrs 41 mins
  • FTSE 100

    5,865.68
    -18.97 (-0.32%)
     
  • FTSE 250

    17,796.62
    -69.46 (-0.39%)
     
  • AIM

    972.69
    -2.42 (-0.25%)
     
  • GBP/EUR

    1.0994
    -0.0002 (-0.01%)
     
  • GBP/USD

    1.2944
    +0.0004 (+0.0298%)
     
  • BTC-GBP

    9,087.82
    +548.04 (+6.42%)
     
  • CMC Crypto 200

    238.80
    +5.13 (+2.20%)
     
  • S&P 500

    3,426.92
    -56.89 (-1.63%)
     
  • DOW

    28,195.42
    -410.89 (-1.44%)
     
  • CRUDE OIL

    40.76
    -0.07 (-0.17%)
     
  • GOLD FUTURES

    1,903.70
    -8.00 (-0.42%)
     
  • NIKKEI 225

    23,567.04
    -104.09 (-0.44%)
     
  • HANG SENG

    24,545.78
    +3.52 (+0.01%)
     
  • DAX

    12,777.09
    -77.57 (-0.60%)
     
  • CAC 40

    4,916.95
    -25.67 (-0.52%)
     

Insights on the High-density Multiplexed Diagnostic Assays Global Market to 2027 - Featuring Abbott Laboratories, Agilent Technologies & Hologic Among Others

Research and Markets
·3-min read

Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "High-density Multiplexed Diagnostic Assays - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 6th edition of this report. The 175-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global High-density Multiplexed Diagnostic Assays Market to Reach $3.2 Billion by 2027

Amid the COVID-19 crisis, the global market for High-density Multiplexed Diagnostic Assays estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 14.4% over the period 2020-2027.

High-Density Multiplexed Diagnostic Assays (500-10,000 plex), one of the segments analyzed in the report, is projected to record 14.1% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Very High-Density Multiplexed Diagnostic Assays (>10,000 plex) segment is readjusted to a revised 14.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $363.6 Million, While China is Forecast to Grow at 13.9% CAGR

The High-density Multiplexed Diagnostic Assays market in the U.S. is estimated at US$363.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$551.1 Million by the year 2027 trailing a CAGR of 13.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 12.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Competitors identified in this market include, among others:

  • Abbott Laboratories

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • Erba Diagnostics, Inc.

  • F. Hoffmann-La Roche AG

  • Gold Standard Diagnostics Corporation

  • Hologic, Inc.

  • Luminex Corporation

  • Randox Laboratories Ltd.

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares

  • High-density Multiplexed Diagnostic Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/8r2w4p

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900